AddThis

Former Campbell Soup exec named EVP sales at Pharmavite

NORTHRIDGE, Calif. — Pharmavite, a U.S. manufacturer of vitamins, minerals and other dietary supplements, announced on Tuesday Timothy Toll as its new EVP sales.

“We are honored to have Mr. Toll join our Pharmavite team, as he has deep and relevant experience delivering impressive growth through strategic business transformation,” said Mark Walsh, COO of Pharmavite. “As a well-rounded, thoughtful and respected business leader, he comes to us with an impressive track record and personal values that make him a terrific fit for our company.”

Toll comes to Pharmavite with nearly 30 years of experience within the consumer packaged goods industry. Most recently, Toll served as global VP of customer strategy for Campbell Soup Co., where he led the sales function for Campbell’s international division, and developed the international sales strategy across 16 markets.

In addition, he was responsible for the joint business plan development for key international markets and global customers, international shopper insights capability, category management, trade spend evaluation, revenue management department design, talent development and emerging market business development focusing on China, Mexico, Indonesia and Brazil.

Prior to his work at Campbell Soup Co., Toll held sales and leadership positions with H.J. Heinz Co. and Proctor & Gamble.

Toll’s strategic priorities will include accelerating the growth of new products in the United States in conjunction with Pharmavite’s parent company, Otsuka Pharmaceutical Co., and maintaining a continued focus on the financial health and effectiveness of Pharmavite’s overall business.

Pharmavite brands portfolio includes Nature Made, Voots Veggie Fruit Tarts and SoyJoy brand names. Based in Northridge, Calif., Pharmavite operates as a subsidiary of Otsuka Pharmaceutical Co.


Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.

© 2014 Drug Store News. All Rights Reserved.